Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01556646 · ClinicalTrials.gov registry record · Phase 3
Effect of Tolvaptan on Cognitive Function in Cirrhosis
A Phase 3 study, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 25
- Enrollment target
NCT01556646 is a Phase 3 study that has completed, run by Hunter Holmes Mcguire Veteran Affairs Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT01556646, a Phase 3 study, has completed, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 25 participants
- Enrollment target
Study Summary
Hypothesis: Tolvaptan will improve cognitive function, brain edema and health-related quality of life in cirrhotic patients with hyponatremia
Interventions
- DRUG Tolvaptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01556646
The ClinicalTrials.gov registry entry for NCT01556646 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tolvaptan is the first listed.
NCT01556646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01556646 about?
NCT01556646 is a clinical study titled "Effect of Tolvaptan on Cognitive Function in Cirrhosis". Hypothesis: Tolvaptan will improve cognitive function, brain edema and health-related quality of life in cirrhotic patients with hyponatremia
What is the current status of trial NCT01556646?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2011-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01556646?
The interventions under investigation include: Tolvaptan (DRUG).
Who is sponsoring clinical trial NCT01556646?
This trial is sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.